TARP and cancer: The hypothesis is that low levels of endogenous TAA and neoantigens that are being released from dying cancer cells during ICD may not be effective for stimulating T-cell antigen receptors, leading to the recruitment of CTLs that exhibit low cytotoxic potential for cancer cells.